Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Lambert

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
BJA Open|August 17, 2023
Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisisDavid G Lambert
Nature Reviews. Drug Discovery|August 2, 2008
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potentialDavid G Lambert
Neuropharmacology|June 28, 2022
Ketamine; history and role in anesthetic pharmacologyKazuyoshi Hirota, David G Lambert
Methods in Molecular Biology (Clifton, N.J.)|February 23, 2011
Measurement of [³H]PN200-110 and [¹²⁵I]ω-conotoxin MVIIA bindingKazuyoshi Hirota, David G Lambert
British Journal of Pharmacology|February 13, 2010
Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptorJohn McDonald, David G Lambert
British Journal of Anaesthesia|February 12, 2024
Danavorexton (TAK-925): an orexin receptor 2 agonist as a new 'arousal' agentDavid G Lambert, Kazuyoshi Hirota
British Journal of Anaesthesia|December 31, 2022
Celebrating the first centenary of the British Journal of Anaesthesia: a century of discovery and disseminationHugh C Hemmings, David G Lambert
The Journal of Physiology|December 25, 2004
{alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscleDavid G Lambert, Gail D Thomas
Current Opinion in Supportive and Palliative Care|April 15, 2015
Simultaneous targeting of multiple opioid receptor typesMark F Bird, David G Lambert
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Ratiometric [Ca²⁺]i measurements in adherent cell-lines using the NOVOstar microplate readerBenjamin D Hunt, David G Lambert
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
BJA Open|August 17, 2023
Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisisDavid G Lambert
Nature Reviews. Drug Discovery|August 2, 2008
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potentialDavid G Lambert
Neuropharmacology|June 28, 2022
Ketamine; history and role in anesthetic pharmacologyKazuyoshi Hirota, David G Lambert
Methods in Molecular Biology (Clifton, N.J.)|February 23, 2011
Measurement of [³H]PN200-110 and [¹²⁵I]ω-conotoxin MVIIA bindingKazuyoshi Hirota, David G Lambert
British Journal of Pharmacology|February 13, 2010
Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptorJohn McDonald, David G Lambert
British Journal of Anaesthesia|February 12, 2024
Danavorexton (TAK-925): an orexin receptor 2 agonist as a new 'arousal' agentDavid G Lambert, Kazuyoshi Hirota
British Journal of Anaesthesia|December 31, 2022
Celebrating the first centenary of the British Journal of Anaesthesia: a century of discovery and disseminationHugh C Hemmings, David G Lambert
The Journal of Physiology|December 25, 2004
{alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscleDavid G Lambert, Gail D Thomas
Current Opinion in Supportive and Palliative Care|April 15, 2015
Simultaneous targeting of multiple opioid receptor typesMark F Bird, David G Lambert
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Ratiometric [Ca²⁺]i measurements in adherent cell-lines using the NOVOstar microplate readerBenjamin D Hunt, David G Lambert
Pageof 10